These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Liver-Microbiome Axis in Health and Disease. Adolph TE; Grander C; Moschen AR; Tilg H Trends Immunol; 2018 Sep; 39(9):712-723. PubMed ID: 29843959 [TBL] [Abstract][Full Text] [Related]
24. Microbial Profiles of Cirrhosis in the Human Small Intestine. Dong TS; Jacobs JP; Hussain SK Curr Gastroenterol Rep; 2019 Aug; 21(10):50. PubMed ID: 31444636 [TBL] [Abstract][Full Text] [Related]
25. [The role of gut microbiota in chronic liver diseases, and treatment possibilities]. Hagymási K; Bacsárdi A; Egresi A; Berta E; Tulassay Z; Lengyel G Orv Hetil; 2018 Sep; 159(36):1465-1474. PubMed ID: 30175608 [TBL] [Abstract][Full Text] [Related]
26. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Suk KT; Kim DJ Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767 [TBL] [Abstract][Full Text] [Related]
27. Non-alcoholic fatty liver and the gut microbiota. Bashiardes S; Shapiro H; Rozin S; Shibolet O; Elinav E Mol Metab; 2016 Sep; 5(9):782-94. PubMed ID: 27617201 [TBL] [Abstract][Full Text] [Related]
28. The intestinal microbiome and paediatric liver disease. Leung DH; Yimlamai D Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):446-455. PubMed ID: 28497760 [TBL] [Abstract][Full Text] [Related]
29. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? Jiang L; Schnabl B Physiology (Bethesda); 2020 Jul; 35(4):261-274. PubMed ID: 32490750 [TBL] [Abstract][Full Text] [Related]
31. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. Cho MS; Kim SY; Suk KT; Kim BY J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993 [TBL] [Abstract][Full Text] [Related]
32. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis. Qamar AA J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961 [TBL] [Abstract][Full Text] [Related]
33. Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease. Stärkel P; Schnabl B Semin Liver Dis; 2016 Sep; 36(4):331-339. PubMed ID: 27997973 [TBL] [Abstract][Full Text] [Related]
35. Alcohol, liver disease and the gut microbiota. Bajaj JS Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):235-246. PubMed ID: 30643227 [TBL] [Abstract][Full Text] [Related]
36. Nonalcoholic Fatty Liver Disease and the Gut Microbiome. Boursier J; Diehl AM Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268 [TBL] [Abstract][Full Text] [Related]
37. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma. Roderburg C; Luedde T Gut Microbes; 2014 Jul; 5(4):441-5. PubMed ID: 25006881 [TBL] [Abstract][Full Text] [Related]
38. NAFLD, Helicobacter species and the intestinal microbiome. Castaño-Rodríguez N; Mitchell HM; Kaakoush NO Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):657-668. PubMed ID: 29566909 [TBL] [Abstract][Full Text] [Related]
39. Investigation of etiology-specific alterations in the gut microbiota in liver cirrhosis. Naseri M; Houri H; Yadegar A; Asadzadeh Aghdaei H; Zahiri J Expert Rev Gastroenterol Hepatol; 2021 Dec; 15(12):1435-1441. PubMed ID: 34632902 [TBL] [Abstract][Full Text] [Related]